Company Overview 

News & Media

Join Our Team

News & Events

Our resource center provides company news, thought leadership content, and upcoming virtual events.

Posts about

Analytical Development

Press Release: Alcami Adds Solid-State Characterization Capabilities

Morrisville, North Carolina – September 22, 2022 – Alcami, a U.S.-based pharmaceutical contract...

Alcami Adds Additional Formulation Development Capabilities

Formulation Development Suite to Support Small and Large Molecule Programs

Morrisville, North...

Alcami Expands Biologics Footprint with Investment in Durham

$10 Million Investment Doubles Laboratory Footprint & Enhances Large Molecule and Cell & Gene...

Bioanalytical Testing Trends in 2022

An increasing number of clinical trial registrations, more R&D investment, growing demand for...

Alcami Announces the Acquisition of Masy BioServices

Acquisition to add 375,000 ft² of cGMP Biostorage and Pharma Support Services

 

Alcami to Provide Analytical Support Services for Novavax’ COVID-19 Vaccine Candidate

DURHAM, N.C. – November 16, 2021 – Alcami, a leading United States-based contract development and...

Outsourcing Trends in the Development of Biologics

The development of biologic drugs continues to increase at a rapid pace. Growing numbers of...

Fill-Finish Development Challenges & Solutions for CDMOs

Recently, contract development and manufacturing organizations (CDMOs) involved in the...

White Paper: Host Cell Impurities, Bioassays, Micro-Flow Imaging

As opposed to traditional drug production, the production of biological products (biologics)...

On-Demand Lab Open House

From standalone projects through full-service programs, our laboratories provide solutions to your...

White Paper: Leveraging Inductively Coupled Plasma Mass Spectrometry To Its Full Potential

Today’s technology has not only changed the way we receive information, but has continually adapted...

Full-Time Equivalent Programs: Outsourcing Analytical Testing

Alcami’s end-to-end analytical testing platform supports clients’ programs through every stage of a

Benefits of Establishing a Full-Time Equivalent (FTE) Program

A Full-Time Equivalent (FTE) agreement is a comprehensive analytical service that grants...

Alcami Helps Secure FDA Approval for MDGH

Durham, NC (USA) – October 25, 2018 – Alcami Corporation, a leading provider of fully-integrated...

ON-DEMAND WEBINAR: Extractables & Leachables

Requirements from regulatory agencies have become increasingly rigorous with regards to the...

The Role of FTE (FULL TIME EQUIVALENT) Programs

An FTE agreement is considered a comprehensive analytical service that allows pharmaceutical and...

Abuse-Deterrent Studies – An Interview with Angela Moore

As one of the key contributors to current abuse-deterrent studies being performed in the Alcami...